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Summary 
The use of magnetic resonance imaging ( MRI) in gynecological oncology is rapidly expanding. Pelvic MRI has excel-
lent soft tissue contrast and multiplanar imaging ability to demonstrate either normal or pathological processes. In gyneco-
logical oncology the rapidly evolving role of MRI includes not only diagnosis but also disease staging, planning of therapy 
and monitoring response to treatment. We perform around 350 preoperative gynecology MRI annually, mostly in patients 
with suspected malignancy. In this paper we review the role of MRI in endometrial, cervical and ovarian cancer. 
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MRI U GINEKOLOŠKOJ ONKOLOGIJI
Sažetak
Svakodnevno raste uporaba magnetske rezonancije (MR) u ginekološkoj onkologiji. MR zdjelice ima odličnu prostor-
nu i kontrastnu rezoluciju za prikaz kako fi zioloških tako i patoloških procesa. Sve je veća uključenost MR pregleda ne samo 
u dijagnostici već i u određivanju stadija bolest i praćenju terapije. U našem radiološkom odjelu obavi se oko 350 preopera-
tivnih ginekoloških MR pregleda godišnje, najčešće kod pacijenata sa sumnjom na malignu bolest. U ovom radu osvrnuti 
ćemo se na ulogu MR u karcinomima endometrija, grlića maternice i jajnika.
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INTRODUCTION
Magnetic resonance imaging (MRI) in gyne-
cology is now frequently used. MRI is the imaging 
technique with the highest contrast and anatomic 
resolution for soft tissues, becoming the modality 
of choice for morphological evaluation of pelvic 
disease. Diff usion-weighted imaging (DWI), pro-
vides information on the random motion of water 
molecules in tissue and dynamic contrast en-
hanced (DCE) MRI depicts the distribution of con-
trast agent by measuring tissue enhancement and 
variations in vessels. MRI is used in clinical stag-
ing in gynecological oncology, planning of thera-
py and monitoring response to treatment.
MRI OF ENDOMETRIAL CANCER
In endometrial cancer, MRI is used to identi-
fy myometrial invasion and extra uterine spread-
ing, allowing preoperative surgical planning. Pre-
operative MRI helps in classifying tumors accord-
ing to International association of gynecological 
oncology (FIGO) classifi cation. Normal or thick-
ened endometrial stripe with diff use or focal ab-
normal signal and intact junctional zone is staged 
as FIGO IA stage, while in FIGO IB stage signal 
intensity of tumor extends into less than half en-
dometrium with partial disruption of junctional 
zone. FIGO IC stage present when signal intensity 
of tumor extends into more than half of myome-
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trium and junctional zone is fully disrupted, while 
FIGO IIA stage shows widening of cervical canal 
with low signal of cervical stroma which presents 
invasion of endocervix. FIGO IIB stage shows cer-
vical stromal invasion with disruption of low sig-
nal stroma. In FIGO IIIA stage we can see disrup-
tion of continuity of outer myometrium with or 
without irregular uterine confi guration. FIGO IIB 
stage also shows invasion of vagina. Pelvic or pa-
ra-aortic lymphadenopathy in FIGO IIIC stage 
presents as regional or para-aortic nodes larger 
than 1cm in short axis diameter. FIGO IVA stage 
Figure 1.2.
Figure 1.1.
shows invasion of bladder or rectal mucosa and 
FIGO IVB stage shows distant metastases includ-
ing intraabdominal lymphadenopathy. The over-
all staging accuracy of conventional MRI imaging 
was reported to be 83% to 92%, with 87% of sen-
sitivity and 91% of specifi city in assessing myo-
metrial infi ltration, 80% of sensitivity and 96 of 
specifi city for cervical invasion, and 50% of sensi-
tivity and 95% of specifi city for lymph node as-
sessment (1). 
Figure 1.1. T2WI sagitt al image presents nor-
mal uterus zonal anatomy where we can see a thin 
black line (arrow) that present junctional zone and 
white normal thick endometrium. 
Figure 1.2. T2WI presents coronal view of 
small left-side endometrial cancer, staged as IB.
 MRI OF CERVICAL CANCER
Uterine cervical cancer is one of the most 
common malignancies seen by gynecological radi-
ologists. In cervical cancer MRI has a role in local 
staging. By assessing the proximal extension of 
tumors in young women, MRI determines the fea-
sibility of fertility-preserving surgery (trachelec-
tomy). It is also used to plan and administer radio-
therapy. This optimises tumor irradiation while 
limiting unwanted irradiation of the intestines 
and other pelvic organs. 
Cervical cancer can be endophytic, exophytic 
or infi ltrative. It has high signal intensity on T2WI 
Figure 2.1.
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sequence, while normal cervical stroma is low sig-
nal intensity. For detection of abdominal lymph 
nodes it is important to inspect all the structures 
up to the renal hilum. The most important for 
staging and FIGO classifi cation is the description 
of parametrial or vaginal infi ltration. The overall 
stagging accuracy of MRI ranges from 77%-90% 
(2,3). The reported accuracy of MRI in detection of 
parametrial invasion ranges from 77% to 96% (2)
Figure 2.1. and 2.2 present infi ltrative cervi-
cal cancer that spreads in parametrium. In the fi rst 
image we can see dorsal spreading and exofi tic 
growth, while second image presents left side in-
fi ltrative spreading.
Figure 2.3. presents endophitic cervical tu-
mor. This patient is candidate for fertility-preserv-
ing surgery.
MRI OF OVARIAN CANCER
Masses in ovaries can be solid, cystic or com-
plex. In ovarian cancer MRI is useful in young 
women in diagnosing endometriomas, dermoids 





Libri Oncol., Vol. 43 (2015), No 1–3, 29 – 32
32
sound as malignant lesions. Features that can be 
seen in an adnexal mass on MRI that are associat-
ed with malignancy are: a mixed solid–cystic le-
sion, irregularity and vegetation of the wall or 
septa in a cystic lesion, larger than 4 cm, early en-
hancement on dynamic contrast-enhanced MR 
images, and the presence of ascites, peritoneal dis-
ease or adenopathy. In patients with clinically or 
sonographically detected complex or adnexal 
masses, MRI imaging was shown to have 91% ac-
curacy for the diagnosis of malignancy (4). 
In 3.1. image we can see a large bilateral 
mostly cystic process which represents bilateral 
serous cystadenocarcinoma of ovary, while on 3.2. 
image we can see also a large cystic process that is 
well demarcated lesion that represents cystadeno-
ma of right ovary. Ascites is present because of the 
mass eff ect and not as a sign of malignancy.
CONCLUSION
This article reviews the role of MRI in the 
three most common gynecological malignancies. 
Owing to its superior soft tissue delineation and 
multiplanar capability, MRI is considered the 
most accurate imaging modality for preoperative 
evaluation of gynecological cancers. The role of 
MRI is increasing both due to its ability to show 
the pelvic structure with high precision showing 
also their vascularisation patt erns. The increasing 
availability of MR technology should benefi t pa-
tients with pelvic malignancies in diagnosis, pre-
operative staging and follow up.
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